Other languages Interpace Biosciences, Inc.

Equities

IDXG

US46062X3035

Delayed OTC Markets Other stock markets 12:45:43 26/06/2024 am IST			5-day change	1st Jan Change
1.16 ^USD	-5.36%		-3.09%	+7.41%

04/06	Interpace Diagnostics Announces New Data Analyzing Imbalance of Short Tandem Repeat Alleles for Pancreatic Cancer Detection Published as an ASCO 2024 Abstract	CI
09/05	Interpace Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Interpace Diagnostics Announces New Data Analyzing Imbalance of Short Tandem Repeat Alleles for Pancreatic Cancer Detection Published as an ASCO 2024 Abstract	04/06
Interpace Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05
Interpace Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	07/03
Interpace Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	07/03
Robert Gorman Provides Notice to Interpace Biosciences, Inc. of His Resignation as A Director and as Chairman of the Board, Including as A Member of the Board?s Regulatory Compliance Committee	13/12
Interpace Biosciences, Inc. Announces Resignation of Edward Chan as Class II Director	17/11
Interpace Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Interpace Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	09/23/09
Interpace Biosciences, Inc. Expects to Stop Offering Pancragen Test Due to CMS Decision to End Reimbursement as of July 17, 2023	06/23/06
Interpace Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	13/23/13
Interpace Biosciences, Inc. Appoints Christopher Mccarthy as Principal Financial Officer	25/23/25
Interpace Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	28/23/28
Interpace Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	28/23/28
Interpace Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28
Interpace Biosciences, Inc. Auditor Raises 'Going Concern' Doubt	27/23/27
Interpace Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15
Interpace Biosciences, Inc. Announces New Clinical Validation Data	02/22/02
Flagship Biosciences, Inc. acquired Interpace Pharma Solutions from Interpace Biosciences, Inc..	31/22/31
Interpace Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/22/16
Earnings Flash (IDXG) INTERPACE BIOSCIENCES Posts Q2 Revenue $9.4M	16/22/16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Interpace Biosciences, Inc.

Equities

IDXG

US46062X3035

Other languages

Filters